Supply Notification: H2-antagonists (Cimetidine, Famotidine and Nizatidine) – Update

Supply Notification: H2-antagonists (Cimetidine, Famotidine and Nizatidine) – Update

October 28, 2020

Update (28/10/2020): resupply dates now expected:

Product Supplier Current Stock Position Anticipated Resupply date Detail
Famotidine 20mg tablets Tilomed Laboratories Limited supplies Early December 2020 Unlicensed supplies have been sourced
Teva UK Out of stock Mid November 2020
Famotidine 40mg tablets Tilomed Laboratories In stock N/A
Teva UK Limited supplies End November 2020
Cimetidine 200mg tablets Ennogen Pharma Out of stock June 2021 Unlicensed supplies have been sourced
Medreich Out of stock to be confirmed
Cimetidine 400mg tablets Ennogen Pharma Out of stock June 2021
Medreich Out of stock to be confirmed
Cimetidine 800mg tablets Ennogen Pharma Out of stock June 2021
Medreich Out of stock to be confirmed
Cimetidine 200mg/5ml oral solution Rosemont Pharmaceuticals In stock n/a
Nizatidine 150mg tablets Mylan Out of stock Early January 2021 Unlicensed supplies have been sourced
Medreich Out of stock to be confirmed
Relonchem Out of stock End November 2020
Nizatidine 300mg tablets  Mylan Out of stock Early January 2021 Unlicensed supplies of Nizatidine 150mg capsules have been sourced
Medreich Out of stock to be confirmed
Relonchem Out of stock Mid November 2020

The following specialist importers have confirmed they can source unlicensed cimetidine tablets (please note, there may be other companies that can also source supplies):

The following specialist importers have confirmed they can source unlicensed famotidine tablets 20mg and 40mg  (please note, there may be other companies that can also source supplies):

The following specialist importers have confirmed they can source unlicensed Nizatidine capsules (please note, there may be other companies that can also source supplies):

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Cimetidine (strength) tablets cannot be issued. Where a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

 

Department of Health and Social Care (DHSC) has issued a medicine supply notification for H2-antagonists (Cimetidine, Famotidine and Nizatidine)

Suppliers of Cimetidine, Famotidine and Nizatidine have reported an increase in demand, which has contributed to short term shortages of Cimetidine 200mg tablets, Famotidine 20mg tablets, and Nizatidine 150mg and 300mg tablets.

  • Famotidine 20mg tablets are out of stock until the end of December 2019.
  • Cimetidine 200mg tablets are out of stock until the end of January 2020.
  • Nizatidine 150mg and 300mg tablets are out of stock until February 2020.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.



Posted in:


More Latest News >